A research team in Carnegie Mellon University's Ray and Stephanie Lane Computational Biology Department is working to better understand the role that genetic on and off switches play in activating ...

This Initiative could favorably contribute to medical practice years from now. It should not, however, overshadow the potential of neurogenomic advances to improve the diagnosis, treatment and ...

Tempus AI will collaborate with Northwestern University's neurogenomics researchers to use artificial intelligence to accelerate discovery of treatments for Alzheimer's disease, the Chicago-based ...

My curiosity about my leukocytes started before the pandemic. I was motivated by the oldest and most basic grief we experience: the loss of love. But the lessons from my heartache and the emerging ...

Nature Neuroscience presents a series of Perspectives and Reviews highlighting recent advances in understanding the genetics of complex brain disorders. Previously intractable to the approaches of ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with The Abrams ...

Join Dr. Kelly Jin as she discusses new research on how our brains change as we age. Dr. Jin talks about a newly released dataset that reveals how specific brain cell types undergo gene expression ...

The Computational Medicine Center (CMC), an Ohio Third Frontier-funded research collaboration between Cincinnati Children's and UC, has purchased Evotec Technologies' ultra-High-Throughput Screening ...